Request Trial
shutterstock-101016205-toria-shutterstock-com
Toria / Shutterstock.com
7 October 2016Big Pharma

Event preview: Life Sciences Patents Network Europe 2016

Newton Media, the publisher of Life Sciences IP Review, is excited to host this publication’s first event. On December 7, 2016, the best and brightest people working in life sciences intellectual property, including in-house counsel and private practitioners, will converge on the Bloomsbury Hotel in London for a day of networking, education and debate.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Part II: The race to replace semaglutide heats up
23 March 2026   With Novo Nordisk's core semaglutide patent expired in India last week, the company that built one of the most successful drugs in pharmaceutical history is already fighting on a new front. So what comes next?
Big Pharma
Sandoz strikes fresh biosimilar deal with South Korean biotech
19 March 2026   The Swiss generics giant secures global commercialisation rights as partnership targets multi-billion-dollar loss-of-exclusivity opportunity.
Big Pharma
INTA: ‘New normal’ for in-house counsel as budgets fall
16 March 2026   Research from the International Trademark Association finds in-house counsel taking on more strategic work while facing shrinking budgets, prompting a shift towards alternative billing and greater use of AI.


Editor's picks

Masimo convinces judge that Apple took secrets—but it’s not enough
Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
19 March 2026

Editor's picks

Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
19 March 2026
Americas
LSPN Awards 2026 finalists revealed
2 March 2026
Americas
SCOTUS flooded with briefs calling for reversal of ‘skinny label’ ruling
26 February 2026
Americas
Eli Lilly escapes $278m payout in biotech licensing dispute
26 February 2026
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026
Asia
AstraZeneca partners with Chinese firm ahead of next obesity race
5 February 2026

More features

Part II: The race to replace semaglutide heats up
Part I: Ozempic goes generic as Novo’s key patent expires
Masimo convinces judge that Apple took secrets—but it’s not enough
Sandoz strikes fresh biosimilar deal with South Korean biotech
US firm boosts patent bench with Desmarais hire
J&J unit targets former employee over alleged mass data theft
HSF Kramer hires patent litigator as partner in Germany
INTA: ‘New normal’ for in-house counsel as budgets fall